Stories from people navigating cardiovascular-kidney-metabolic syndrome — diagnosis, treatment, caregiving, and the ordinary days in between.
4 stories
Cardiology
The 2026 CKM guideline calls for earlier, integrated prevention when cardiovascular, kidney and metabolic risks coexist, with action spanning primary care, endocrinology, nephrology and cardiology.
Dr. Abu Bakar · August 30, 2026 · 7 min
Cardiology
The 2026 multisociety guideline defines a unified pathway for evaluating cardiovascular, kidney and metabolic risk, particularly when disease or risk factors overlap.
Rayan Salih · 7 min read
Endocrinology & Metabolism
A secondary analysis found that finerenone reduced cardiovascular and kidney events across CKM stages in adults with type 2 diabetes and CKD, while favoring CKM stage regression over progression.
Dr. Abu Bakar · 7 min read
Health Policy
The 2026 joint guideline links lipid management to CKM stage and PREVENT-ASCVD risk, with explicit LDL-C, non-HDL-C and apoB goals for US adults.
Rayan Salih · 7 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.